Treprostinil Palmitil Inhalation Powder (TPIP)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Treprostinil Palmitil Inhalation Powder (TPIP), covering 2026-02-27 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) [Phase 2, Phase 3]